Drug Interactions between aspirin / diphenhydramine / phenylpropanolamine and trichophyton skin test
This report displays the potential drug interactions for the following 2 drugs:
- trichophyton skin test
Interactions between your drugs
diphenhydrAMINE trichophyton skin test
Applies to: aspirin / diphenhydramine / phenylpropanolamine and trichophyton skin test
DiphenhydrAMINE may interfere with your response to trichophyton skin test. If you are currently using or have recently used diphenhydrAMINE, let your doctor know before you get tested with trichophyton skin test. It is generally best to discontinue diphenhydrAMINE for 2 to 4 days before testing, but you should check with your doctor. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
Applies to: aspirin / diphenhydramine / phenylpropanolamine
Using phenylpropanolamine with alcohol can increase the risk of cardiovascular side effects such as increased heart rate, chest pain, or blood pressure changes. In addition, you may also be more likely to experience nervous system side effects such as dizziness, drowsiness, depression, and difficulty concentrating. You should avoid or limit the use of alcohol while being treated with phenylpropanolamine. Do not use more than the recommended dose of phenylpropanolamine, and avoid activities requiring mental alertness such as driving or operating hazardous machinery until you know how the medication affects you. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medication without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.